Mitesco, Inc.
For the period ended Mar 31, 2026. Filed May 20, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 20, 2026
MITIStored price and day change unavailable
Contents
Item 1. Consolidated Balance Sheets as of March 31, 2026, and December 31, 2025
CONSOLIDATED BALANCE SHEETS
| March 31, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| (Unaudited) | ||
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $1,533 | $100,857 |
| Accounts receivable, net | 27,600 | 27,600 |
| Prepaid expenses and other current assets | 2,296 | 3,651 |
| Total current assets | 31,429 | 132,108 |
| Total Assets | $31,429 | $132,108 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities | $4,085,528 | $4,027,183 |
| Accrued interest | 440,348 | 398,356 |
| Derivative liabilities | 403,548 | 399,160 |
| Deferred Revenue | 10,000 | 10,000 |
| Lease liability - operating leases, current | 99,477 | 99,477 |
| Notes payable, net of discounts | 639,416 | 639,416 |
| SBA loan payable | 363,216 | 367,801 |
| Convertible Notes Payable, Net | 637,468 | 503,341 |
| Other current liabilities | 96,136 | 96,136 |
| Preferred stock dividends payable | 26,314 | 26,314 |
| Legal settlements | 3,450,831 | 3,387,536 |
| Series A preferred stock liability, current | 9,242,699 | 9,447,335 |
| Total current liabilities | 19,494,981 | 19,402,055 |
| Series A preferred stock liability, non-current | 4,428,395 | 4,202,644 |
| Total liabilities | 23,923,376 | 23,604,699 |
| Commitments and contingencies (Note 12) | ||
| Stockholders’ deficit | ||
| Preferred stock, $0.01 par value, 100,000,000 shares authorized; 10,000,000 shares designated Series D; 10,000 shares designated as Series E; 140,000 shares designated as Series F; and 400,000 shares designated Series X: | ||
| Preferred stock, Series D, $0.01 par value, no shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively | - | - |
| Preferred stock, Series F, $0.01 par value, no shares issued and outstanding as of March 31, 2026, and December 31, 205, respectively | - | - |
| Preferred stock, Series X, $0.01 par value, 42,103 shares issued and outstanding March 31, 2026, and December 31, 205, respectively | 421 | 421 |
| Common stock, $0.01 par value, 500,000,000 shares authorized, 17,795,540 and 15,093,055 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively | 177,955 | 150,931 |
| Additional paid-in capital | 40,063,593 | 39,732,684 |
| Accumulated deficit | (64,133,916) | (63,356,627) |
| Total stockholders’ deficit | (23,891,947) | (23,472,591) |
| Total liabilities and stockholders’ deficit | $31,429 | $132,108 |
See accompanying notes to these unaudited consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.